The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Shilpa Medicare's Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.

Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

CPHI China has long been recognized as a premier platform for connecting the entire pharmaceutical supply chain, from active ...

Laurus Labs pharma stock jumps 23 per cent in one month on strong CDMO growth, FY25 earnings, and margin expansion.

Laurus Labs shares rose over 2% in Monday's trading, marking three days of gains. In June 2025, the stock has gained 18%, ...

India has also proposed a strategic alignment with Washington’s 'Make in America' policy, suggesting that the final stages of drug processing, including semi-finished and finished dosage forms ...

Priyanka Sharma , Dhirendra Kumar 5 min read 28 May 2025, 06:00 AM IST ...

Finished Dosage Form (FDF) Capabilities: The Company produces pharmaceutical-grade MDMA and psilocybin in both active pharmaceutical ingredient (API) form and as encapsulated, ready-to-administer ...

For children who are receiving chemotherapy and are 4 to 11 years old, the typical dosage of ondansetron oral forms is 4 mg taken 30 minutes before chemotherapy starts. At 4 hours later, another 4 ...

As the subsidiary of Viva Biotech Holdings, the leading enterprise in the field of innovative drug discovery, we offer our worldwide partners a One-Stop CDMO solution in new drugs' entire life cycle ...